Advertisement
Advertisement
NKTR
Nektar Therapeutics
35.19
USDSponsored
-0.72
-2.01%
Jan 29, 15:59 UTC -5
Closed
After-Market
35.28
+0.09
+0.27%
NKTR Earnings Reports
Positive Surprise Ratio
NKTR beat 32 of 40 last estimates.
80%
Next Report
Date of Next Report
Mar 10, 2026
Estimate for Q4 25 (Revenue/ EPS)
$10.39M
/-$2.47
Implied change from Q3 25 (Revenue/ EPS)
-11.87%
/+32.09%
Implied change from Q4 24 (Revenue/ EPS)
-64.38%
/+2.92%
Nektar Therapeutics earnings per share and revenue
On Nov 06, 2025, NKTR reported earnings of -1.87 USD per share (EPS) for Q3 25, beating the estimate of -2.73 USD, resulting in a 31.71% surprise. Revenue reached 11.79 million, compared to an expected 10.25 million, with a 15.03% difference. The market reacted with a +1.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -2.47 USD, with revenue projected to reach 10.39 million USD, implying an increase of 32.09% EPS, and decrease of -11.87% in Revenue from the last quarter.
FAQ
What were Nektar Therapeutics's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Nektar Therapeutics reported EPS of -$1.87, beating estimates by 31.71%, and revenue of $11.79M, 15.03% above expectations.
How did the market react to Nektar Therapeutics's Q3 2025 earnings?
The stock price moved up 1.54%, changed from $55.12 before the earnings release to $55.97 the day after.
When is Nektar Therapeutics expected to report next?
The next earning report is scheduled for Mar 10, 2026.
What are the forecasts for Nektar Therapeutics's next earnings report?
Based on 10
analysts, Nektar Therapeutics is expected to report EPS of -$2.47 and revenue of $10.39M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement